Key actions by disease
Consultations
Useful resources
/photostory/2021-waaw-viet-nam/waaw-2021-viet-nam-photo-story-7.jpg?sfvrsn=12ba95bc_7 "A technician prepares a microscopic slide in a laboratory in Hanoi, Viet Nam")
Related activities
Online learning
All →/clinical-trials-for-new-re-emerging-pathogens-gpp-module-1.tmb-549v.png?sfvrsn=6d4247d9_1)
Documents
All →
WHO Technical Advisory Group – candidate vaccine prioritization: summary of the evaluations and recommendations...
To date four candidate vaccines have been evaluated at meetings that took place between 20 February and 30 March 2023, with a further meeting on 17 October...
Marburg virus – Therapeutics prioritisation
Prioritization of candidate treatments to be included in a randomized clinical trial
/r-d-blue-print-(rdb)/cover-page-filovirus-treatments_core-trial-protocol.tmb-144v.jpg?sfvrsn=c4fa6505_2)
Solidarity Partners – Platform adaptive randomized trial for new and repurposed Filovirus treatments...
This protocol was written in accordance with the trial design and drug selection recommendations from the Filovirus therapeutics working group at WHO....
WHO Target Product Profiles for mpox Vaccines
This document describes the preferred and minimally acceptable profiles for human vaccines for all clades of mpox. All vaccines considered for use...
Publications
All →
This large, international, randomized controlled clinical trial is designed to enable an expeditious, agile and concurrent evaluation of the benefits and...
WHO R&D Blueprint COVID-19: Informal consultation on the potential inclusion of Favipiravir in a clinical...
There has been some suggestions for the inclusion of Favipiravir in the Solidarity trial.
Currently, there are no licensed vaccines for the prevention of COVID 19. While efforts continue to develop effective vaccines, it is pertinent to examine...
